Delivery Order FA486121D0004-FA486122F0068
Award Date 3/11/22
Potential Completion Date 3/17/23
Potential Value $142K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Las Vegas, NV 89101, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Air Force Air Combat Command awarded a $124,588.79 firm fixed price delivery order to Genomic Health, Inc. for Oncotype DX cancer testing services during the ordering period from March 2023 through March 2024. Genomic Health is a subsidiary of Exact Sciences Corporation which will perform the testing through its laboratory services division Exact Sciences Laboratories. The delivery order was awarded without a set-aside designation to support the Air Force's cancer screening...
- This federal contract award is for Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX cancer testing services to the U.S. Air Force's Air Combat Command. The delivery order is valued at $124,588.79 and has a period of performance from March 16, 2024 to March 15, 2025, with a total contract period extending to March 2025. Genomic Health has been awarded multiple prime federal contracts and task orders from agencies such as the Department of Veterans...
- Genomic Health, Inc., a subsidiary of Exact Sciences Corp, has been awarded a $62,259.50 firm fixed price delivery order against an unspecified contract vehicle to provide oncotype dx cancer testing services for the United States Air Force Air Combat Command located at Nellis Air Force Base in Nevada. Oncotype dx cancer testing analyzes gene expression in breast and prostate cancers to determine a recurrence score that predicts the likelihood of cancer returning after initial treatment. The...
- This is a firm fixed-price delivery order awarded by the Air Education and Training Command, a defense agency, to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of Oncotype DX Pathology Tests, which are advanced genomic cancer diagnostic services. This order is placed under the Medical Laboratory Testing and Analysis Services contract vehicle, a General Services Administration (GSA) schedule. Genomic Health provides these...
- This is a delivery order awarded to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of Oncotype cancer testing services to the Defense Health Agency (DHA). The contract has a ceiling value of $124,588.79 and a period of performance from March 16, 2025, to March 15, 2026, with the testing to be performed at Nellis Air Force Base in Nevada. The contract is a firm fixed-price type and does not have a set-aside designation. Genomic Health, Inc. is a for-profit...
- The Department of the Air Force Materiel Command awarded a $41,186.49 firm fixed price call against a blanket purchase agreement to Genomic Health, Inc. for medical products or services. Performance will occur in Wright-Patterson, Ohio. Genomic Health is a subsidiary of Exact Sciences Corp, which will perform the work through its Exact Sciences Laboratories division under the Exact brand name. No set aside provisions were included. This contract provides the Air Force Materiel Command with...
- This is a Definitive Contract awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype DX cancer testing services. The $642,816.16 firm fixed-price contract covers the provision of these specialized genomic diagnostic services to various military and veterans' healthcare facilities, including Travis Air Force Base, from January 1, 2020 to March 31, 2025. Genomic Health, Inc. has significant federal Indefinite Delivery Vehicle (IDV)...
- The Defense Health Agency awarded Genomic Health, Inc. a $145,066.32 firm fixed-price BPA call for Oncotype IQ genomic testing services, with an ultimate completion date of September 7, 2026. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in advanced genetic testing services focused on oncology diagnostics, particularly the Oncotype DX portfolio of gene expression assays. These tests support cancer screening, treatment selection, and disease monitoring across breast,...
- This is a firm fixed-price purchase order awarded by the Air Education and Training Command (AETC), a defense agency, to Genomic Health, Inc. for pathology testing services. The contract has a ceiling value of $3,453.96 and a completion date of October 12, 2018. Genomic Health, Inc. is a subsidiary of Exact Sciences Corporation that specializes in providing advanced genetic testing services, particularly for cancer screening, treatment selection, and disease monitoring. The company has a...
- The Department of the Air Force Materiel Command awarded a $48,094.41 firm fixed price call against a blanket purchase agreement to Genomic Health, Inc. for medical products or services. Performance will occur in Wright-Patterson, Ohio. Genomic Health is a subsidiary of Exact Sciences Corp, which will perform the work through its Exact Sciences Laboratories division. No small business set-aside designation was used for this contract to deliver unspecified medical requirements to the Air Force...